Madame Bioscience PCL (BKK:MADAME)
Thailand flag Thailand · Delayed Price · Currency is THB
0.8300
0.00 (0.00%)
At close: Aug 10, 2026

Madame Bioscience PCL Financials Overview

Millions THB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5281,4782,1232,3022,2281,862
Revenue Growth
-21.22%-30.39%-7.78%3.35%19.61%22.79%
Gross Profit
416.04321.76359.99296.4481.33301.34
Operating Income
-401.02-185.4342.34-166.26-385.44-110.1
Net Income
-160.6245.77-331.63-405.81-422.31-152.43
Earnings Per Share
-0.210.06-0.54-0.66-0.70-0.38
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Business
0.720.992.042.664.4817.28
Selling Skincare Products Business
-197.02----
Packaging Business
-83.2957.56847.96845.1659.43
Food Business
1,2651,2721,4791,7761,7401,198
Elimination
-30.22-75.32-315.66-324.48-361.58-12.65
Total
1,5281,4782,1232,3022,2281,862

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
135.04193.8180.6234.76253.3452.39
Total Debt
216.57243.62614.14819.66921.92323.17
Net Cash (Debt)
-81.52-49.81-533.52-784.91-668.57-270.78
Net Cash Growth
------
Net Cash Per Share
-0.11-0.06-0.86-1.28-1.11-0.68

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1.2339.72227.0171.98-163.44-98.48
Capital Expenditures
-42.74-41.49-15.39-39.61-144.02-206.38
Free Cash Flow
-41.5-1.77211.6232.37-307.46-304.86
Free Cash Flow Growth
--553.65%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
27.22%21.77%16.96%12.88%3.65%16.18%
Operating Margin
-26.24%-12.55%1.99%-7.22%-17.30%-5.91%
Pretax Margin
-10.42%3.38%-15.52%-17.79%-19.94%-10.07%
Profit Margin
-10.51%3.10%-15.62%-17.63%-18.96%-8.19%
FCF Margin
-2.72%-0.12%9.97%1.41%-13.80%-16.37%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-12.36----
P/FCF Ratio
--3.5735.16--
PS Ratio
0.440.380.360.490.931.40